MercoPress. South Atlantic News Agency

Brazil's sanitary watchdog greenlights drug to treat Alzheimer's

Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of Alzheimer's disease in patients with mild cognitive impairment and mild dementia. It works by targeting beta-amyloid plaques in the brain, which are associated with the malady. Read full article